Common Contracts
14 similar Executive Employment Agreement contracts by Tocagen Inc, Seneca Biopharma, Inc., Palisade Bio, Inc.
PALISADE BIO, INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • September 11th, 2023 • Palisade Bio, Inc. • Biological products, (no disgnostic substances) • California
This Executive Employment Agreement (the “Agreement”) is made and entered into effective as of September 5, 2023 (the “Effective Date”), by and between Mitchell Jones, M.D., Ph.D. (“Executive”) and Palisade Bio, Inc. (the “Company”).
LEADING BIOSCIENCES, INC. AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 26th, 2021 • Seneca Biopharma, Inc. • Biological products, (no disgnostic substances) • California
This Amended and Restated Executive Employment Agreement (the “Agreement”) is made and entered into effective as of January 25, 2021 (the “Effective Date”), by and between JD Finley (“Executive”) and Leading BioSciences, Inc. (the “Company”), amending and restating in its entirety the Executive Employment Agreement between Executive and Company dated December 16, 2020, as of the Effective Date.
LEADING BIOSCIENCES, INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • December 23rd, 2020 • Seneca Biopharma, Inc. • Biological products, (no disgnostic substances) • California
This Executive Employment Agreement (the “Agreement”) is made and entered into effective as of December 16, 2020 (the “Effective Date”), by and between JD Finley (“Executive”) and Leading BioSciences, Inc. (the “Company”).
LEADING BIOSCIENCES, INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • December 23rd, 2020 • Seneca Biopharma, Inc. • Biological products, (no disgnostic substances) • California
This Executive Employment Agreement (the “Agreement”) is made and entered into effective as of December 16, 2020 (the “Effective Date”), by and between Michael Dawson, M.D. (“Executive”) and Leading BioSciences, Inc. (the “Company”).
LEADING BIOSCIENCES, INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • December 23rd, 2020 • Seneca Biopharma, Inc. • Biological products, (no disgnostic substances) • California
This Executive Employment Agreement (the “Agreement”) is made and entered into effective as of December 16, 2020 (the “Effective Date”), by and between Thomas Hallam, Ph.D. (“Executive”) and Leading BioSciences, Inc. (the “Company”).
SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 27th, 2020 • Tocagen Inc • Pharmaceutical preparations • California
This Second Amended and Restated Executive Employment Agreement (the “Agreement”) is made and entered into effective as of February 21, 2020 (the “Effective Date”), by and between Martin J. Duvall (“Executive”) and Tocagen Inc. (the “Company”).
SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 27th, 2020 • Tocagen Inc • Pharmaceutical preparations • California
This Second Amended and Restated Executive Employment Agreement (the “Agreement”) is made and entered into effective as of February 21, 2020 (the “Effective Date”), by and between Mark G. Foletta (“Executive”) and Tocagen Inc. (the “Company”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 27th, 2020 • Tocagen Inc • Pharmaceutical preparations • California
This Amended and Restated Executive Employment Agreement (the “Agreement”) is made and entered into effective as of February 21, 2020 (the “Effective Date”), by and between Fairooz Kabbinavar M.D. (“Executive”) and Tocagen Inc. (the “Company”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 27th, 2020 • Tocagen Inc • Pharmaceutical preparations • California
This Amended and Restated Executive Employment Agreement (the “Agreement”) is made and entered into effective as of February 21, 2020 (the “Effective Date”), by and between Douglas J. Jolly, Ph.D. (“Executive”) and Tocagen Inc. (the “Company”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 8th, 2019 • Tocagen Inc • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”) is made and entered into effective as of February 26, 2019 (the “Effective Date”), by and between Fairooz Kabbinavar M.D. (“Executive”) and Tocagen Inc. (the “Company”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 9th, 2018 • Tocagen Inc • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”) is made and entered into effective as of February 12, 2018 (the “Effective Date”), by and between Asha Das, M.D. (“Executive”) and Tocagen Inc. (the “Company”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 9th, 2018 • Tocagen Inc • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”) is made and entered into effective as of February 12, 2018 (the “Effective Date”), by and between Douglas Jolly, Ph.D. (“Executive”) and Tocagen Inc. (the “Company”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 9th, 2018 • Tocagen Inc • Pharmaceutical preparations • California
This Amended and Restated Executive Employment Agreement (the “Agreement”) is made and entered into effective as of February 12, 2018 (the “Effective Date”), by and between Mark Foletta (“Executive”) and Tocagen Inc. (the “Company”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 9th, 2018 • Tocagen Inc • Pharmaceutical preparations • California
This Amended and Restated Executive Employment Agreement (the “Agreement”) is made and entered into effective as of February 12, 2018 (the “Effective Date”), by and between Martin J. Duvall (“Executive”) and Tocagen Inc. (the “Company”).
